[1]
C. L. de S. Cajui et al., “SAFETY ANALYSIS OF IMMUNOBIOLOGICS IN PATIENTS WITH MYASTHENIA GRAVIS: A SYSTEMATIC REVIEW”, REASE, vol. 12, no. 7, pp. 1–22, Jul. 2026, doi: 10.51891/rease.v12i7.27576.